Alerts will be sent to your verified email
Verify Email
MAHAREM
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Indo-American Advanced Pharmaceuticals Ltd focuses on manufacturing a wide range of pharmaceutical formulations including antibiotics, analgesics, and anti-inflammatory drugs such as tablets, capsules, liquids, and ointments.
IndoAmerican Advance major competitors are Krebs Biochem.&Inds, Bal Pharma, Vaishali Pharma, Aarey Drugs & Pharma, Auro Laboratories, Bafna Pharma, Amwill Health Care.
Market Cap of IndoAmerican Advance is ₹171 Crs.
While the median market cap of its peers are ₹173 Crs.
IndoAmerican Advance seems to be less financially stable compared to its competitors.
Altman Z score of IndoAmerican Advance is 0 and is ranked 6 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | ||||||||||||||||||
| Investor Presentation | ||||||||||||||||||
| Conference Call | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
